Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22733020 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed UARK 2003-33, Total Therapy III
Condition: Multiple Myeloma
Interventions: Drug: Velcade;   Drug: Thalidomide

Indicates status has not been verified in more than two years